Percutaneous ultrasound-guided stellate ganglion block for the treatment of arrythmic storm and stage E cardiogenic shock: case report
Stellate ganglion block in the treatment of arrhythmic storm and cardiogenic shock
DOI:
https://doi.org/10.25751/rspa.26814Keywords:
Arrhythmic storm, cardiogenic shock, stellate ganglion, ECMO, electrophysiologic studyAbstract
Arrhythmic storm is a medical emergency that complicates severe structural heart disease and is associated with an increased mortality rate. Antiarrhythmic drugs and catheter ablation are the most commonly used therapies. Alternatively, percutaneous ultrasound-guided stellate ganglion blockade is a promising technique for the control of arrhythmic storm in the event of refractoriness or failure of other approaches. We report a case of therapeutic success of left stellate ganglion block in the control of arrhythmic storm complicated by stage E cardiogenic shock with dependence on support by venoarterial extracorporeal membrane oxygenation and intra-aortic balloon. The percutaneous sympathetic block with bupivacaine allowed the control of arrhythmic storm and the continuation of definitive intervention with electrophysiological study. We highlight the therapeutic potential of a minimally invasive and low-risk intervention in the treatment of arrhythmic storm.
Downloads
References
- Maury P, Mansourati J, Fauchier L, Waintraub X, Boveda S, Sacher F. Management of sustained arrhythmias for patients with cardiogenic shock in intensive cardiac care units. Arch Cardiovasc Dis. 2019;112(12):781–791. doi:10.1016/j.acvd.2019.10.002
- Muser D, Santangeli P, Liang JJ. Management of ventricular tachycardia storm in patients with structural heart disease. World J Cardiol. 2017;9(6):521–530. doi:10.4330/wjc.v9.i6.521
- Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007;12(4):375–382. doi:10.1111/j.1542-474X.2007.00187
- Geraghty L, Santangeli P, Tedrow UB, Shivkumar K, Kumar S. Contemporary Management of Electrical Storm. Heart Lung Circ. 2019;28(1):123–133. doi:10.1016/j.hlc.2018.10.005
- Kontogiannis C, Tampakis K, Georgiopoulos G, Bartoletti S, Papageorgiou C, Anninos H, et al. Electrical Storm: Current Evidence, Clinical Implications, and Future Perspectives. Curr Cardiol Rep. 2019;21(9):96. Published 2019 Jul 27. doi:10.1007/s11886-019-1190-0
- Tian Y, Wittwer ED, Kapa S, McLeod CJ, Xiao P, Noseworthy PA, et al. Effective Use of Percutaneous Stellate Ganglion Blockade in Patients With Electrical Storm. Circ Arrhythm Electrophysiol. 2019;12(9):e007118. doi:10.1161/CIRCEP.118.007118
– Fudim M, Boortz-Marx R, Ganesh A, Waldron NH, Qadri YJ, Patel CB, et al. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(12):1460–1467. doi:10.1111/jce.13324
- Le Pennec-Prigent S, Flecher E, Auffret V, Leurent G, Daubert JC, Leclercq C, et al. Effectiveness of Extracorporeal Life Support for Patients With Cardiogenic Shock Due To Intractable Arrhythmic Storm. Crit Care Med. 2017;45(3):e281-e289. doi:10.1097/CCM.0000000000002089
- Asensio-Samper JM, Sanchís López N, Valía Vera JC, de Andrés Ibáñez J. Left stellate ganglion block in treating electrical storm. Importance of ultrasonography. Rev Esp Cardiol (Engl Ed). 2014;67(1):72–73. doi:10.1016/j.rec.2013.09.006
- Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793‐2867. doi:10.1093/eurheartj/ehv316
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 João Galacho, Doroteia Silva, Nuno Cortez-Dias, João Miguel Ribeiro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.
